Clinical Trial Update: Phase Ib/II Study of Polatuzumab Vedotin in Combination With Rituximab and Chidamide in Newly Diagnosed Elderly Patients With Double-Expressor DLBCL [Phase 1, Phase 2]

View source ↗

Summary

This is an early-phase clinical trial evaluating polatuzumab vedotin in combination with rituximab and chidamide for newly diagnosed elderly patients with doubl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Rituximab (rituximab)
• polatuzumab vedotin (polatuzumab vedotin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Double Expressor DLBCL | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING